{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:07Z","timestamp":1790115007710,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>From 2019 (pre-COVID-19) to 2022 (COVID-19 years), three tertiary Greek hospitals monitored MDRO bloodstream infection (BSI) and hospital acquisition relying on laboratory data. Surveillance covered carbapenem-resistant <jats:italic>Enterobacterales<\/jats:italic> (CRE), <jats:italic>Acinetobacter baumannii<\/jats:italic> (CRAB), <jats:italic>Pseudomonas aeruginosa<\/jats:italic> (CRPA), vancomycin-resistant enterococci (VRE), and methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), in intensive care units (ICUs) and non-ICUs. Non-ICUs experienced significant increases in CRE, CRAB and VRE during the pandemic. In ICUs, CRE increased in 2021, CRAB in 2020 and 2021, and VRE in 2021 and 2022. KPC predominated among CRE. MDRO BSI and hospital acquisition incidence rates increased, driven by CRE and CRAB.<\/jats:p>","DOI":"10.1007\/s10096-024-04806-x","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T10:02:02Z","timestamp":1711447322000},"page":"1241-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multidrug-resistant organism bloodstream infection and hospital acquisition among inpatients in three tertiary Greek hospitals during the COVID-19 era"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3768-4023","authenticated-orcid":false,"given":"Polyxeni","family":"Karakosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Vourli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Kousouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Meletis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areti","family":"Tychala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Louka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Vasilakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Protonotariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Mamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olympia","family":"Zarkotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemonia","family":"Skoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyros","family":"Pournaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"4806_CR1","doi-asserted-by":"publisher","unstructured":"CDC. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. Atlanta, GA: U.S. Department of Health and Human Services [Internet] (2022) 14;399:629\u201355. https:\/\/doi.org\/10.15620\/cdc:117915","DOI":"10.15620\/cdc:117915"},{"key":"4806_CR2","doi-asserted-by":"publisher","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A et al Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022 12;399:629\u2013655. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"4806_CR3","unstructured":"Executive Summary Policy Pathways to Combat the Global Crisis of Antimicrobial Resistance www.asm.org\/advocacy 1 [Internet]. doi: www.asm.org\/advocacy"},{"key":"4806_CR4","doi-asserted-by":"publisher","unstructured":"EClinicalMedicine Antimicrobial resistance: a top ten global public health threat. EClinicalMedicine 2021 1;41. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101221","DOI":"10.1016\/j.eclinm.2021.101221"},{"key":"4806_CR5","doi-asserted-by":"publisher","unstructured":"Monnet DL, Harbarth S Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? Euro 2020 1;25:1\u20136. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.45.2001886","DOI":"10.2807\/1560-7917.ES.2020.25.45.2001886"},{"key":"4806_CR6","doi-asserted-by":"publisher","unstructured":"Kritsotakis EI, Kontopidou F, Astrinaki E, Roumbelaki M, Ioannidou E, Gikas A Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece. Infect Drug Resist 2017 10;10:317\u2013328. https:\/\/doi.org\/10.2147\/IDR.S147459","DOI":"10.2147\/IDR.S147459"},{"key":"4806_CR7","doi-asserted-by":"publisher","unstructured":"Ioannou P, Astrinaki E, Vitsaxaki E, Bolikas E, Christofaki D, Salvaraki A et al A Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in Public Acute Care Hospitals in Crete, Greece. Antibiotics 2022 1;11. https:\/\/doi.org\/10.3390\/antibiotics11091258","DOI":"10.3390\/antibiotics11091258"},{"key":"4806_CR8","doi-asserted-by":"publisher","unstructured":"Cassini A, H\u00f6gberg LD, Plachouras D, Quattrocchi A, Hoxha A, Simonsen GS et al Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis 2019 1;19:56\u201366. https:\/\/doi.org\/10.1016\/S1473-3099(18)30605-4","DOI":"10.1016\/S1473-3099(18)30605-4"},{"key":"4806_CR9","doi-asserted-by":"publisher","unstructured":"Polemis M, Mandilara G, Pappa O, Argyropoulou A, Perivolioti E, Koudoumnakis N et al COVID-19 and antimicrobial resistance: data from the greek electronic system for the surveillance of antimicrobial resistance\u2014WHONET-Greece (January 2018\u2013March 2021). Life 2021 1;11. https:\/\/doi.org\/10.3390\/life11100996","DOI":"10.3390\/life11100996"},{"key":"4806_CR10","unstructured":"CDC\u2019s National Healthcare Safety Network Multidrug-Resistant Organism & Clostridioides difficile Infection (MDRO\/CDI) Module [Internet]. January 2024 2024;1\u201352. doi: https:\/\/www.cdc.gov\/nhsn\/psc\/cdiff\/index.html"},{"key":"4806_CR11","unstructured":"EUCAST Clinical breakpoints - breakpoints and guidance [Internet]. v 13.1 2022;15. doi: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_12.0_Breakpoint_Tables.pdf"},{"key":"4806_CR12","unstructured":"H H. Analysis of Crude Data. In: Modern epidemiology, ed Rothman KJ. Boston: Little: Brown & Co; (1886)"},{"key":"4806_CR13","volume-title":"Statistics in epidemiology: methods, techniques, and applications","author":"HKA Sahai","year":"1996","unstructured":"Sahai HKA (1996) Statistics in epidemiology: methods, techniques, and applications. CRC, IncTitle;, Boca Raton, FL"},{"key":"4806_CR14","unstructured":"MedCalc Software Ltd Confidence interval for a rate [Internet]. Version 22.018 2023 6;doi: https:\/\/www.medcalc.org\/calc\/rate_ci.php"},{"key":"4806_CR15","doi-asserted-by":"publisher","unstructured":"Bolikas E, Astrinaki E, Panagiotaki E, Vitsaxaki E, Saplamidou S, Drositis I et al Impact of SARS-CoV-2 preventive measures against Healthcare-Associated infections from antibiotic-resistant ESKAPEE pathogens: a Two-Center, Natural Quasi-experimental Study in Greece. Antibiot 2023 22;12:1088. https:\/\/doi.org\/10.3390\/antibiotics12071088","DOI":"10.3390\/antibiotics12071088"},{"key":"4806_CR16","doi-asserted-by":"publisher","unstructured":"Abubakar U, Al-Anazi M, alanazi Z, Rodr\u00edguez-Ba\u00f1o J Impact of COVID-19 pandemic on multidrug resistant gram positive and gram negative pathogens: a systematic review. J Infect Public Health 2023 1;16:320\u2013331. https:\/\/doi.org\/10.1016\/j.jiph.2022.12.022","DOI":"10.1016\/j.jiph.2022.12.022"},{"key":"4806_CR17","doi-asserted-by":"publisher","unstructured":"Micheli G, Sangiorgi F, Catania F, Chiuchiarelli M, Frondizi F, Taddei E et al The Hidden Cost of COVID-19: Focus on Antimicrobial Resistance in Bloodstream Infections. Microorganisms 2023 1;11. https:\/\/doi.org\/10.3390\/microorganisms11051299","DOI":"10.3390\/microorganisms11051299"},{"key":"4806_CR18","doi-asserted-by":"publisher","unstructured":"Vlad ND, Cernat RC, Carp S, Mitan R, Dumitru A, Nemet C et al Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case\u2013control study. Journal of International Medical Research 2022 1;50. https:\/\/doi.org\/10.1177\/03000605221129154","DOI":"10.1177\/03000605221129154"},{"key":"4806_CR19","doi-asserted-by":"publisher","unstructured":"Liu P, Li X, Luo M, Xu X, Su K, Chen S et al Risk factors for Carbapenem-resistant Klebsiella pneumoniae infection: a Meta-analysis. Microb Drug Resist 2018 1;24:190\u2013198. https:\/\/doi.org\/10.1089\/mdr.2017.0061","DOI":"10.1089\/mdr.2017.0061"},{"key":"4806_CR20","doi-asserted-by":"publisher","unstructured":"Langford BJ, So M, Raybardhan S, Leung V, Soucy JPR, Westwood D et al Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect 2021 1;27:520\u2013531. https:\/\/doi.org\/10.1016\/j.cmi.2020.12.018","DOI":"10.1016\/j.cmi.2020.12.018"},{"key":"4806_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2022.823626","volume":"12","author":"C Ayoub Moubareck","year":"2022","unstructured":"Ayoub Moubareck C, Hammoudi Halat D (2022) The collateral effects of COVID-19 pandemic on the Status of Carbapenemase-Producing pathogens. Front Cell Infect Microbiol 12:1\u201311. https:\/\/doi.org\/10.3389\/fcimb.2022.823626","journal-title":"Front Cell Infect Microbiol"},{"key":"4806_CR22","doi-asserted-by":"publisher","unstructured":"Rangel K, Chagas TPG, De-Simone SG (2021) Acinetobacter baumannii infections in times of COVID-19 pandemic. Pathogens 10. https:\/\/doi.org\/10.3390\/pathogens10081006","DOI":"10.3390\/pathogens10081006"},{"key":"4806_CR23","doi-asserted-by":"publisher","unstructured":"Zhou H, Yao Y, Zhu B, Ren D, Yang Q, Fu Y et al (2019) Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia; a retrospective study from a Chinese hospital. Med (United States) 98. https:\/\/doi.org\/10.1097\/MD.0000000000014937","DOI":"10.1097\/MD.0000000000014937"},{"key":"4806_CR24","doi-asserted-by":"publisher","unstructured":"van Dijk MD, Voor in \u2019t holt AF, Alp E, Hell M, Petrosillo N, Presterl E et al (2022) Infection prevention and control policies in hospitals and prevalence of highly resistant microorganisms: an international comparative study. Antimicrob Resist Infect Control. ;11:1\u201311. https:\/\/doi.org\/10.1186\/s13756-022-01165-0","DOI":"10.1186\/s13756-022-01165-0"},{"key":"4806_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1128\/AAC.46.6.1619-1628.2002","volume":"46","author":"S Harbarth","year":"2002","unstructured":"Harbarth S, Cosgrove S, Carmeli Y (2002) Effects of antibiotics on nosocomial epidemiology of Vancomycin-resistant enterococci. Antimicrob Agents Chemother 46:1619\u20131628. https:\/\/doi.org\/10.1128\/AAC.46.6.1619-1628.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"4806_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7326\/0003-4819-135-3-200108070-00009","volume":"135","author":"SK Fridkin","year":"2001","unstructured":"Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R (2001) The Effect of Vancomycin and Third-Generation cephalosporins on Prevalence of Vancomycin-resistant Enterococci in 126 U.S. adult intensive care units. Ann Intern Med [Internet] 135:175\u2013183. https:\/\/doi.org\/10.7326\/0003-4819-135-3-200108070-00009","journal-title":"Ann Intern Med [Internet]"},{"key":"4806_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jac\/dkm416","volume":"61","author":"E Tacconelli","year":"2008","unstructured":"Tacconelli E, De angelis G, Cataldo MA, Pozzi E, Cauda R (2008) Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 61:26\u201338. https:\/\/doi.org\/10.1093\/jac\/dkm416","journal-title":"J Antimicrob Chemother"},{"key":"4806_CR28","unstructured":"European Centre for Disease Prevention and Control (2022) Antimicrobial consumption in the EU\/EEA (ESAC-Net) - Annual Epidemiological Report 2021. Stockholm"},{"key":"4806_CR29","doi-asserted-by":"publisher","unstructured":"Kramer A, Wagenvoort H, Ahr\u00e9n C, Daniels-Haardt I, Hartemann P, Kobayashi H et al (2010) Epidemiology of MRSA and current strategies in Europe and Japan. GMS Krankenhhyg Interdiszip [Internet] 5:Doc01. https:\/\/doi.org\/10.3205\/dgkh000144","DOI":"10.3205\/dgkh000144"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-024-04806-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-024-04806-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T14:09:38Z","timestamp":1718374178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-024-04806-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["4806"],"URL":"https:\/\/doi.org\/10.1007\/s10096-024-04806-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"30 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not obtained for the study since it utilized data from routine surveillance and was not thus necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}